about
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsEpigenomics of leukemia: from mechanisms to therapeutic applicationsEpigenomics of cancer - emerging new conceptsIntegrating Epigenomics into the Understanding of Biomedical InsightEDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting ChemicalsEnvironmental epigenetics and its implication on disease risk and health outcomesEnvironmental epigenetics of asthma: an updateEffects of the demethylating agent, 5-azacytidine, on expression of the kallikrein-kinin genes in carcinoma cells of the lung and pleuraGene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjectsGenome-wide identification of polycomb-associated RNAs by RIP-seqDNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation statusIdentification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genesDNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumorsDNA methyltransferases: a novel target for prevention and therapy.Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcomaEpigenetics meets endocrinology.Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylationEpigenetic modifications by dietary phytochemicals: implications for personalized nutritionDNA methylation of cancer genome.Cancer genetics and epigenetics: two sides of the same coin?Linking epigenetics to lipid metabolism: focus on histone deacetylases.Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicityHistone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies.Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).Regulation of mammalian DNA methyltransferases: a route to new mechanisms.Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent lociHigh throughput screening identifies modulators of histone deacetylase inhibitorsNBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.Folic acid food fortification-its history, effect, concerns, and future directionsEpigenetic activities of flavonoids in the prevention and treatment of cancerSupratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells-148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis.The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription.Genomic Copy Number Variation Affecting Genes Involved in the Cell Cycle Pathway: Implications for Somatic Mosaicism.Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the hostCigarette smoke induces proteasomal-mediated degradation of DNA methyltransferases and methyl CpG-/CpG domain-binding proteins in embryonic orofacial cells.
P2860
Q26744212-2E49C30E-713F-4F87-90CE-BCF39AF3A921Q26823403-A9A81173-4B67-4520-84F9-51619FD968BBQ26830534-56299247-03A9-4BD3-A635-0C71AEED42F9Q28077579-06D941DC-D553-4854-A908-4E92D7FB0971Q28383132-01A64D04-7A5F-457A-AA1C-F9B5FA8F044CQ28385993-61169259-9C2A-4D89-A7F8-EBD764F8A450Q28388771-48B5D67D-ACFA-4BFE-9B19-ABA5E4D8D6B5Q28391556-78AEBCA8-637A-4A0F-87C7-327E7351A4A9Q28394091-60285F28-FAB1-4012-B315-BB8C3F28615CQ28513635-73B8AE86-8291-4702-B14B-851E426FC1D1Q28544885-5DDDE9BA-6A7B-440E-87D7-DA0F92CB67B4Q28592846-74A11E49-C6D4-4BA5-B51E-EF8BFA78911FQ33360111-44957BD9-6858-4885-8578-2D0D832153B2Q33415036-DD76CA87-FC70-484C-BF57-6D26B0A962FAQ33436058-9B6F0430-F510-4ECE-ABC7-E504E175FB99Q33540881-9FF4905B-68BF-4BE6-8FB1-E4939FF669D4Q33579896-BB5B5880-EE1D-48B9-8E29-5AB8648BCF30Q33737393-0A7782B3-AC9A-4A32-BC40-273B3A10F64BQ33810295-F2842D05-7D47-405B-B6A6-DD544BA722A0Q33983526-3EA019B7-1407-468C-B545-71EDEE67CDEEQ34129835-33475F91-0B20-4566-97CE-81352C174C0BQ34133706-9709D5F5-137C-4DCA-9B8E-F5C703B279C8Q34287662-3F419E14-E092-4F76-A512-F7C10B0075F4Q34308013-5ABC6B38-0F29-48C1-94C1-C3E46F2D688FQ34320074-2053B668-0242-4315-BCE2-25D35D2D16F4Q34399444-8D04B290-7457-4467-98D4-9CE9150E15C5Q34674178-0C3EBACD-11A3-45B1-B892-BC9E7F77C6A3Q35084510-7A7160F2-5278-4A98-B507-487C5326CEB9Q35153463-B4FF21F4-82A2-4626-831A-60482525C4F8Q35195856-61035494-2967-45F8-83B4-0F9A0CAB37CBQ35419727-0F989D15-889E-45AB-83FC-BFAA4AA3E785Q35671211-8C1DF2CB-47C4-472C-9BC2-FC89464A2720Q35835175-198F4CE9-6917-4004-91D8-69E36F427141Q35863933-D02337B5-79D8-48B4-97C3-FD7831798FE5Q35870127-ACCE3836-CD5B-496F-83DC-D25B33658FF2Q35915333-6639B4E4-F535-4194-8AE2-3C47CFB65DABQ35949401-56563CD6-DF3D-4EDE-9A38-7652B6099971Q36059501-8A3A87AB-B37F-47A9-9D55-E8BB169D9066Q36257990-58E3B89B-91BD-4686-883B-1BC8EA9EDD5FQ36403139-A1A7EAD6-2FDB-4495-8C09-9A65F7BCACB1
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cancer genetics of epigenetic genes.
@en
type
label
Cancer genetics of epigenetic genes.
@en
prefLabel
Cancer genetics of epigenetic genes.
@en
P2860
P356
P1476
Cancer genetics of epigenetic genes.
@en
P2093
Ahmad Miremadi
Mikkel Z Oestergaard
P2860
P304
P356
10.1093/HMG/DDM021
P478
16 Spec No 1
P577
2007-04-01T00:00:00Z